Saluda Medical Revenue and Competitors
Estimated Revenue & Valuation
- Saluda Medical's estimated annual revenue is currently $182.7M per year.
- Saluda Medical's estimated revenue per employee is $351,400
- Saluda Medical's total funding is $124.5M.
Employee Data
- Saluda Medical has 520 Employees.
- Saluda Medical grew their employee count by 22% last year.
Saluda Medical's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief People Officer | Reveal Email/Phone |
2 | Area VP | Reveal Email/Phone |
3 | Chief Financial Officer | Reveal Email/Phone |
4 | VP, Regulatory Affairs | Reveal Email/Phone |
5 | Head European Sales | Reveal Email/Phone |
6 | VP Scientific Affairs | Reveal Email/Phone |
7 | Head Sales Enablement + Senior Sales Director | Reveal Email/Phone |
8 | VP Global Marketing | Reveal Email/Phone |
9 | SVP, Regulatory Affairs and Quality Assurance | Reveal Email/Phone |
10 | Head Data Analytics | Reveal Email/Phone |
Saluda Medical Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $182.7M | 520 | 22% | $124.5M | N/A |
#2 | $33.9M | 135 | -2% | N/A | N/A |
#3 | $5.4M | 43 | -23% | $20.8M | N/A |
#4 | $14.3M | 57 | 10% | N/A | N/A |
#5 | $33.4M | 133 | -13% | $5M | N/A |
#6 | $19.3M | 77 | 8% | N/A | N/A |
#7 | $28.4M | 113 | -3% | N/A | N/A |
#8 | $257.3M | 1025 | 0% | N/A | N/A |
#9 | $22.6M | 90 | -2% | N/A | N/A |
#10 | $35.9M | 143 | 8% | N/A | N/A |
What Is Saluda Medical?
Saluda Medical is a start-up medical device company. Saluda Medical develops advanced fully implantable neuromodulation systems for the next generation of implantable stimulation devices. We are a cutting edge, progressive, 100% Australian company at the forefront of spinal cord stimulation technologies for the management of chronic pain
keywords:N/A
$124.5M
Total Funding
520
Number of Employees
$182.7M
Revenue (est)
22%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Saluda Medical News
2) The $125m private equity of Saluda Medical by Fidelity Management & Research,Redmile Group and T Rowe Price Associates.
Saluda Medical, which is developing a spinal neuromodulation system, landed $125 million in equity financing at the beginning of March.
Saluda Medical has finalised US$125 million in equity financing, with the proceeds being used in part to operationalise and scale...
NEW YORK, July 6, 2021 /PRNewswire-PRWeb/ -- Saluda Grade (SG) has completed a transformative capital raise of $100 million through a first-ever Collateralized Asset Financing (CAF) securitization. The private placement was structured and placed by Jefferies, with an oversubscription of demand f ...
ARTARMON, Australia, Feb. 12, 2021 /PRNewswire/ -- Saluda Medical Pty Limited ("Saluda Medical"), the market leader in the development of novel closed-loop spinal cord stimulation (SCS) for the treatment of chronic pain, today announced the appointment of Jim Schuermann as President & Chief Ex ...
Other Companies in Artarmon
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $475.8M | 1172 | 5% | N/A |
#2 | $502.8M | 1752 | 3% | N/A |